Chronic urticaria: The autoimmune paradigm

Internal Medicine Journal

Volumn 38, Issue 11, 2008, Pages 852-857

  Philpott, H ^a,b   Kette, F ^a   Hissaria, P ^a   Gillis, D ^a   Smith, W ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Autoantibodies; Autoimmune; Histamine; Mast cells; Wheals

Indexed keywords

AMINE; ANTIHISTAMINIC AGENT; AUTOANTIBODY; CETIRIZINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXEPIN; FC RECEPTOR; FOOD ADDITIVE; GLUTAMIC ACID; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOMODULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; OPIATE; PLACEBO; PREDNISOLONE; SALICYLIC ACID; THYROID ANTIBODY; THYROTROPIN; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CHRONIC DISEASE; CHRONIC URTICARIA; CLINICAL FEATURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FOOD ALLERGY; HUMAN; INFECTION; LABORATORY TEST; LOW DRUG DOSE; MAST CELL; MAST CELL DEGRANULATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEDATION; SEROLOGY; SIDE EFFECT; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; URTICARIA; VASCULITIS;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; HUMANS; URTICARIA;

EID: 57649198152     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01673.x     Document Type: Review

References (37)

1. Weldon DR. Quality of life in patients with urticaria. Allergy Asthma Proc 2006 27 : 96 9.
2. Sabroe RA, Greaves MW. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol 2006 154 : 813 19.
3. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007 37 : 631 50.
4. Gaig P, Olona M, Munoz Lejarazu D, Caballero MT, Dominguez FJ, Echechipia S et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004 14 : 214 20.
5. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002 346 : 175 9.
6. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000 105 : 664 72.
7. Varadarajulu S. Urticaria and angioedema. Postgrad Med 2005 117 : 25.
8. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004 114 : 465 74 quiz 75.
9. Male D, Brostoff J, Roth D, Roitt I. Immunology, 7th edn. London : Mosby Elsevier 2006.
10. Hoskin SL, Wilson SJ, Sabine RA, McEwen AR, Grattan CE, Greaves MW et al. Basophil infiltration in chronic idiopathic urticaria. J Allergy Clin Immunol 2002 109 : 587.
11. O'Donnell BF, O'Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999 140 : 853 8.
12. Confino-Cohen R, Aharoni D, Goldberg A, Gurevitch I, Buchs A, Weiss M et al. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 2002 109 : 349 56.
13. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997 99 : 461 5.
14. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993 328 : 1599 604.
15. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998 101 : 243 51.
16. Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998 101 : 672 6.
17. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999 140 : 446 52.
18. Grattan CE. Autoimmune urticaria. Immunol Allergy Clin North Am 2004 24 : 163 81 v.
19. Zweiman B, Valenzano M, Atkins PC, Tanus T, Getsy JA. Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 1996 98 : 89 98.
20. Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002 109 : 114 18.
21. Puccetti A, Bason C, Simeoni S, Millo E, Tinazzi E, Beri R et al. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005 35 : 1599 607.
22. Horn MP, Pachlopnik JM, Vogel M, Dahinden M, Wurm F, Stadler BM et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J 2001 15 : 2268 74.
23. O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005 153 : 331 5.
24. Gibson A, Clancy R. Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors. Clin Allergy 1980 10 : 699 704.
25. Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995 75 : 484 7.
26. Zuberbier T, Pfrommer C, Specht K, Vieths S, Bastl-Borrmann R, Worm M et al. Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 2002 109 : 343 8.
27. Loblay RH, Swain AR, Soutter VR. Friendly Foods: The Essential Guide to Avoiding Allergies, Additives and Problem Chemicals. Sydney : Murdoch Books 2004.
28. Greaves MW. Chronic urticaria. N Engl J Med 1995 332 : 1767 72.
29. Kozel MM, Moein MC, Mekkes JR, Meinardi MM, Bossuyt PM, Bos JD. Evaluation of a clinical guideline for the diagnoses of physical and chronic urticaria and angioedema. Acta Derm Venereol 2002 82 : 270 74.
30. Simons FE. Advances in H1-antihistamines. N Engl J Med 2004 351 : 2203 17.
31. Dibbern DA. Urticaria: selected highlights and recent advances. Med Clin North Am 2006 90 : 187 209.
32. Goldsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986 78 : 867 73.
33. Katelaris CH, Peake JE. 5. Allergy and the skin: eczema and chronic urticaria. Med J Aust 2006 185 : 517 22.
34. Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004 34 : 182 6.
35. Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000 143 : 365 72.
36. Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007 99 : 190 93.
37. Chang TW, Shiung YY. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 2006 117 : 1203 12.